Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

20083,003 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 372, Issue 9637, pp. 449-456

Field-Weighted Citation Impact: 198.54